Net selling: insiders sold $2.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
D.E. Shaw
$24.4M
added
Millennium
$24.0M
added
Sells/Trims (1)
Millennium
$22.0M
trimmed
No tracked top-trader positions in OMDA as of Oct 24, 10:08 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.02 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.08 / -$0.02Alpha Vantage | +$0.10 beat | $87.8M No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.05 / -$0.04Alpha Vantage | +$0.09 beat | $78.0M No estimate | Unavailable |
| Dec 31, 2025 | Mar 5, 2026 | $0.16 / $0.03Alpha Vantage | +$0.13 beat | $75.8M No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.03 / -$0.07Alpha Vantage | +$0.10 beat | $68.0M No estimate | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$0.22 / -$0.15Alpha Vantage | -46.67% miss | $61.4M No estimate | Unavailable |
| Mar 31, 2025 | May 9, 2025 | Unavailable | - | $55.0M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $68.0M | $75.8M | $78.0M | $87.8M |
| Cost of what it sold | $23.0M | $22.2M | $29.4M | $24.0M |
| Gross profit | $45.1M | $53.7M | $48.7M | $63.8M |
| What it spent | ||||
| Research and development | $10.3M | $11.6M | $739.0K | $14.6M |
| Sales and admin | $14.3M | $14.2M | $2.0M | $15.7M |
| Other operating costs | $22.9M | $24.6M | $50.8M | $29.9M |
| Total operating expenses | $47.6M | $50.4M | $53.5M | $60.2M |
| What was left | ||||
| Operating profit | -$2.5M | $3.3M | -$4.8M | $3.5M |
| Interest on debt | $353.0K | $13.0K | $18.0K | $14.0K |
| Profit before tax | -$3.2M | $5.2M | -$3.0M | $5.3M |
| Net profit | -$3.2M | $5.2M | -$3.0M | $5.3M |
| EBITDA | -$1.8M | $6.6M | -$1.4M | $6.9M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace